Ticker Symbol: ABBV
Abbvie Inc
$116.42 - 20-12-2024 4 p.m. ET
Exchange: NEW YORK STOCK EXCHANGE INC.
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001551152
Company Profile
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 1 N Waukegan Rd
Website: https://www.abbvie.com/
CEO: Richard Gonzalez
Tags:
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:01 PM EST
Previous Close: $146.22
Change:
$0.71
(
0.49%)
Days Range: $145.22 - $147.50
Beta: 0.18
52wk. High: $162.75
52wk. Low: $128.24
Ytd. Change -5.37%
50 Day Moving Average: $148.66
200 Day Moving Average: $144.47
Shares Outstanding: 1765046680
Valuation
Market Cap: 25.8T
PE Ratio: 30.03
EPS (TTM): 4.87
Dividends
Dividend Per Share (TTM): $5.83
Dividend Yield (TTM): 3.99%
Ex-Dividend Date: October 12, 2023